| Wal-mart Pharmacy 10-1514 | |
| 2201 Michigan Ave, Arnold, Missouri 63010 | |
| (636) 282-2657 |
| Name | Wal-mart Pharmacy 10-1514 |
|---|---|
| Organization Name | Wal-mart Stores East Lp |
| Location | 2201 Michigan Ave, Arnold, Missouri 63010 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (636) 282-2657 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Cardinal Bank announced today that the Cardinal Bank Community Fund has awarded $5,000 to the Prevent Cancer Foundation. The mission of the Alexandria-based organization is to save lives through cancer prevention and early detection, and it has provided more than $130 million to support cancer prevention, early detection research, education, advocacy, and community outreach nationwide.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients. Its positive safety profile has been confirmed also in a market exposure of 34.5 million patient years. Convincing safety data for patients with a high cardiovascular risk were collected in the three long-term outcome trials ONTARGET, PRoFESS and TRANSCEND which followed some of the patients for up to five years.
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) at the University of Barcelona (UB) have coordinated a research into how the IDPN nitrile causes neurological syndromes similar to those of the amyotrophic lateral sclerosis (ALS), a severe neuromuscular degenerative disease.
› Verified 6 days ago
| NPI Number | 1780601047 |
| Organization Name | WAL-MART STORES EAST LP |
| Doing Business As | WAL-MART PHARMACY10-1514 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2201 Michigan Ave, Arnold, MO 63010 |
| Phone Number | 636-282-2657 |
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Cardinal Bank announced today that the Cardinal Bank Community Fund has awarded $5,000 to the Prevent Cancer Foundation. The mission of the Alexandria-based organization is to save lives through cancer prevention and early detection, and it has provided more than $130 million to support cancer prevention, early detection research, education, advocacy, and community outreach nationwide.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients. Its positive safety profile has been confirmed also in a market exposure of 34.5 million patient years. Convincing safety data for patients with a high cardiovascular risk were collected in the three long-term outcome trials ONTARGET, PRoFESS and TRANSCEND which followed some of the patients for up to five years.
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) at the University of Barcelona (UB) have coordinated a research into how the IDPN nitrile causes neurological syndromes similar to those of the amyotrophic lateral sclerosis (ALS), a severe neuromuscular degenerative disease.
› Verified 6 days ago
News Archive
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Cardinal Bank announced today that the Cardinal Bank Community Fund has awarded $5,000 to the Prevent Cancer Foundation. The mission of the Alexandria-based organization is to save lives through cancer prevention and early detection, and it has provided more than $130 million to support cancer prevention, early detection research, education, advocacy, and community outreach nationwide.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients. Its positive safety profile has been confirmed also in a market exposure of 34.5 million patient years. Convincing safety data for patients with a high cardiovascular risk were collected in the three long-term outcome trials ONTARGET, PRoFESS and TRANSCEND which followed some of the patients for up to five years.
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) at the University of Barcelona (UB) have coordinated a research into how the IDPN nitrile causes neurological syndromes similar to those of the amyotrophic lateral sclerosis (ALS), a severe neuromuscular degenerative disease.
› Verified 6 days ago
Cvs Pharmacy #10071 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2120 Lone Star Dr, Arnold, Missouri 63010 Phone: (636) 287-1381 | |
Cvs Pharmacy #16623 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3849 Vogel Rd, Arnold, Missouri 63010 Phone: (636) 287-1339 | |
Cvs Pharmacy #18020 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3900 Vogel Rd, Arnold, Missouri 63010 Phone: (636) 282-7555 | |
Walgreens #4972 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3937 Vogel Rd, Arnold, Missouri 63010 Phone: (636) 282-7068 | |
Dierbergs Arnold Commons Pharmacy Type: Community/Retail Pharmacy Location: 860 Arnold Commons Dr, Arnold, Missouri 63010 Phone: (636) 282-4817 |